Works matching IS 14741776 AND DT 2005 AND VI 4 AND IP 5
Results: 21
Interferences: rights of the first inventor in the US.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 365, doi. 10.1038/nrd1725
- By:
- Publication type:
- Article
An array of problems.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 362, doi. 10.1038/nrd1746
- By:
- Publication type:
- Article
FDA pharmacogenomics guidance sends clear message to industry.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 359, doi. 10.1038/nrd1745
- By:
- Publication type:
- Article
Mergers in Japan help firms retain own products.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 358, doi. 10.1038/nrd1744
- By:
- Publication type:
- Article
Third Tysabri adverse case hits drug class.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 357, doi. 10.1038/nrd1743
- By:
- Publication type:
- Article
G-protein-coupled receptors: Better beta-blockers.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 371, doi. 10.1038/nrd1713
- By:
- Publication type:
- Article
Regulators of apoptosis: suitable targets for immune therapy of cancer.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 399, doi. 10.1038/nrd1717
- By:
- Publication type:
- Article
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 421, doi. 10.1038/nrd1718
- By:
- Publication type:
- Article
Rho kinase, a promising drug target for neurological disorders.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 387, doi. 10.1038/nrd1719
- By:
- Publication type:
- Article
Elucidating mechanisms of drug-induced toxicity.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 410, doi. 10.1038/nrd1720
- By:
- Publication type:
- Article
Timeline: The rise and rise of drug delivery.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 381, doi. 10.1038/nrd1721
- By:
- Publication type:
- Article
Outlook: Cancer drug discovery through collaboration.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 375, doi. 10.1038/nrd1722
- By:
- Publication type:
- Article
From the analyst's couch: Type 2 diabetes market.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 367, doi. 10.1038/nrd1723
- By:
- Publication type:
- Article
Clofarabine.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Drug delivery: Principles of penetration.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 372, doi. 10.1038/nrd1732
- By:
- Publication type:
- Article
Cardiovascular disease: New use for cannabinoids.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 374, doi. 10.1038/nrd1733
- By:
- Publication type:
- Article
Gene therapy: Permanent correction without selection.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 372, doi. 10.1038/nrd1736
- By:
- Publication type:
- Article
More to the fore.
- Published in:
- 2005
- Publication type:
- Editorial
Proteases: Joint advantage.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 373, doi. 10.1038/nrd1740
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 374, doi. 10.1038/nrd1741
- Publication type:
- Article
Robert Langer.
- Published in:
- Nature Reviews Drug Discovery, 2005, v. 4, n. 5, p. 366, doi. 10.1038/nrd1747
- By:
- Publication type:
- Article